Latest Breaking News On - Natural killer cell - Page 5 : comparemela.com

Susanna | The JOY FM

6 upcoming webinars to support your laboratory workflows

Presentations on HTPLC, antimicrobial resistance, precision medicine, preparative liquid chromatography, and more

GT Biopharma Presented Preclinical Data Demonstrating Novel Mesothelin-Targeted TriKE Driving Cytotoxicity Across All Stages of Non-Small Cell Lung Cancer at ESMO TAT 2022

Gregory Berk, M.D., the Company s President of R&D and Chief Medical Officer noted, "This pre-clinical evidence suggests, despite the difference in circulating immune cells of Stage IVB NSCLC patients, a mesothelin-targeted TriKE can work alongside current standard of care and provide benefit even in the hypoxic environment of a solid

GT Biopharma to Present Pre-Clinical Data at Upcoming Medical Conferences

Driving NK cell immunotherapy against NSCLC, in the context of hypoxia, using Tri-specific Killer Engager (TriKE)

Hematopoietic Cell Discovered to Persist and Cause Leukemia Remission Among Patients

The hematopoietic cell resembled a natural killer cell which caused leukemia remission in a new study.